Publication | Open Access
Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis
38
Citations
7
References
2020
Year
Our study reveals a plasma chemokine signature that can be used as a novel biomarker for predicting adverse treatment outcomes in PTB.
| Year | Citations | |
|---|---|---|
Page 1
Page 1